GREENHALGH ELLIS SKOTT (Chief Science Officer) received a stock award from TELA BIO, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/25/2022ACC: 0001062993-22-005779
Officer· Chief Science Officer
Since Nov 2019
+10.57K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
10.57K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.90K
Price / share
—
Trade value
—
% of position
15.7%
2/23/2022
24.90K→28.80K
Total
Net shares
+3.90K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/23/2022 | A · Award | +3.90K | — | — | 15.7% | 24.90K | 28.80K |
| Total | +3.90K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
6.67K shares
Shares
+6.67K
Strike price
11.75
Held after
6.67K
Exercisable
—
2/23/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock6.67K shares | 2/23/2022 | A · Award | +6.67K | 11.75 | — | 6.67K |